C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 31/00 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 16/18 (2006.01) C12N 15/12 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2621363
Antibodies which target clusterin, a protein involved in the epithelial-to- mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumour cell activity through binding to clusterin.
Selon l'invention, les anticorps qui ciblent la clusterine, une protéine jouant un rôle dans la transition épithéliale-à-mésenchymateuse (EMT) des cellules carcinomateuses, sont identifiés et caractérisés. Ces anticorps peuvent être utilisés pour moduler l'activité des cellules tumorales par une liaison à la clusterine.
Cantin Christiane
Ekiel Irena
Lenferink Anne E.g.
O'connor-Mccourt Maureen D.
Forget Janique
National Research Council Of Canada
LandOfFree
Methods and compositions for modulating tumor cell activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for modulating tumor cell activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for modulating tumor cell activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1680644